CN Patent
CN113620948B — 帽依赖性核酸内切酶抑制剂
Assigned to Taijing Pharmaceutical Research And Development Beijing Co ltd · Expires 2022-11-25 · 3y expired
What this patent protects
本发明提供一种用于抑制流感病毒复制的式(I)化合物、其药学上可接受的盐、代谢物或前药: 所述化合物能够用于制备成治疗流感的药物。本发明还公开了制备它们的方法以及包含所述化合物与药学上可接受的载体的组合物。
USPTO Abstract
本发明提供一种用于抑制流感病毒复制的式(I)化合物、其药学上可接受的盐、代谢物或前药: 所述化合物能够用于制备成治疗流感的药物。本发明还公开了制备它们的方法以及包含所述化合物与药学上可接受的载体的组合物。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.